FDA 483 - R.S.A. Corp. - February 21, 2025

R.S.A. Corp. in Danbury, CT, an API manufacturer, was cited for significant quality control deficiencies during an FDA inspection. Observations included failures in raw material testing, supplier qualification, deviation investigations, analytical method procedures, and equipment cleaning validation. These issues indicate a lack of robust controls over critical aspects of API manufacturing.